Navigation Links
Rock concert aids cancer research
Date:1/18/2011

Rock legends The Who performed alongside Jeff Beck, Blondie singer Debbie Harry and The Verve's Richard Ashcroft. They wowed a packed house and glittering list of celebrities to raise funds for PDT.

The work carried out by Dr. Alison Curnow and her team at the Peninsula Medical School and Royal Cornwall Hospital in Truro, UK, was given an immediate grant from the Killing Cancer charity of 30,000, which came from the proceeds of the concert.

Dr. Curnow commented: "The Peninsula Medical School PDT research team and the very busy dermatology PDT service led by Dr. Sandra Campbell at the Royal Cornwall Hospital are delighted with the generous support provided by Killing Cancer. It was a fantastic show and this funding will enable us to continue our clinical PDT research for another year. PDT is still a relatively little know light-activated anti-cancer drug therapy that can be used topically to destroy certain types of skin cancer without scarring."

David Longman, director of Killing Cancer, added: "Alison's team is doing amazing work in Cornwall. The concert was a great success and it was good to be able to make an immediate grant to recognise quickly the way Alison and her team are developing the use of PDT. The charity and the rock legends who supported us wanted to recognise the incredible research work, dedication and determination of Alison and her team."


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1

Related medicine news :

1. dbMaestro Achieves “Ready For IBM Rational Software” Validation For Rational Team Concert Integration
2. Hospitals and Health Systems Have a New Solution for Zero Footprint Image Exchange; Orion Health Announces Concerto Enterprise Image Viewer
3. U-M researchers find indirect path to attack breast cancer stem cells
4. Oncology basic research director at John Theurer Cancer Center continues transplantation research
5. Scientists bring cancer cells back under control
6. Scientists identify avoidable breast cancer risk factors
7. Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams
8. Thorough Exams a Must for Those at High Risk of Skin Cancer
9. Breast Cancer Radiation Before 1984 Tied to Heart Disease
10. Study Finds Racial Disparity in Breast Cancer Outcomes
11. Study provides molecular rationale for combining targeted agents to treat breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: